4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          We aimed to investigate the effects of miR-34a-5p on c-fos regulation mediating the malignant behaviors of SH-SY5Y cells infected with Kaposi’s sarcoma-associated herpesvirus (KSHV).

          Methods

          The KSHV-infected (SK-RG) and uninfected SH-SY5Y parent cells were compared for differentially expressed miRNAs using transcriptome sequencing. Then miR-34a-5p was upregulated in SK-RG cells by the miRNA mimics transfection. Cell proliferation ability was determined by MTT and plate clone assays. The cell cycle was assessed by flow cytometry analysis, and CDK4, CDK6, cyclin D1 levels were determined by Western blot analysis. The migration behavior was detected by wound healing and transwell assays. The protein levels of MMP2 and MMP9 were measured by Western blot analysis. The regulation of c-fos by miR-34a-5p was detected by the dual-luciferase reporter gene assay. Rescue assays were carried out by upregulating c-fos in miR-34a-5p-overexpressing SK-RG cells. KSHV DNA copy numbers and relative virus gene expressions were detected. Xenograft tumor experiments and immunohistochemistry assays were further used to detect the effects of miR-34a-5p.

          Results

          miR-34a-5p was lower in SK-RG cells. Restoration of miR-34a-5p decreased cell proliferation and migration, leading to a G1 cell cycle arrest and down-regulation of CDK4/6, cyclin D1, MMP2, MMP9. KSHV copy number and expression of virus gene including latency-associated nuclear antigen (LANA), replication and transcription activator (RTA), open reading frame (K8.1), and KSHV G protein-coupled receptor (v-GPCR) were also reduced. Furthermore, c-fos is the target of miR-34a-5p, while enhanced c-fos weakened cellular behaviors of miR-34a-5p-overexpressing cells. Xenograft experiments and immunohistochemistry assays showed that miR-34a-5p inhibited tumor growth and virus gene expression.

          Conclusion

          Upregulated miR-34a-5p in KSHV-infected SH-SY5Y cells suppressed cell proliferation and migration through down-regulating c-fos. miR-34a-5p was a candidate molecular drug for KSHV-infected neuronal cells.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          An overview of microRNAs: Biology, functions, therapeutics, and analysis methods

          MicroRNAs (miRNAs) are a class of small noncoding RNAs, which function in posttranscriptional regulation of gene expression. They are powerful regulators of various cellular activities including cell growth, differentiation, development, and apoptosis. They have been linked to many diseases, and currently miRNA-mediated clinical trial has shown promising results for treatment of cancer and viral infection. This review provides an overview and update on miRNAs biogenesis, regulation of miRNAs expression, their biological functions, and role of miRNAs in epigenetics and cell-cell communication. In addition, alteration of miRNAs following exercise, their association with diseases, and therapeutic potential will be explained. Finally, miRNA bioinformatics tools and conventional methods for miRNA detection and quantification will be discussed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            MiRNA Biogenesis and Regulation of Diseases: An Overview.

            MicroRNAs (miRNAs) are small RNA molecules, with their role in gene silencing and translational repression by binding to target mRNAs. Since it was discovered in 1993, miRNA are found in all eukaryotic cells conserved across the species. In recent years, regulation of miRNAs are extensively studied for their role in biological processes as well as in development and progression of various human diseases including retinal disorder, neurodegenerative diseases, cardiovascular disease and cancer. This chapter summarises miRNA biogenesis and explores their potential roles in a variety of diseases. miRNAs holds huge potential for diagnostic and prognostic biomarkers, and as predictors of drug response.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship.

              MicroRNAs (miRNAs) have emerged as key gene regulators in diverse biological pathways. These small non-coding RNAs bind to target sequences in mRNAs, typically resulting in repressed gene expression. Several methods are now available for identifying miRNA target sites, but the mere presence of an miRNA-binding site is insufficient for predicting target regulation. Regulation of targets by miRNAs is subject to various levels of control, and recent developments have presented a new twist; targets can reciprocally control the level and function of miRNAs. This mutual regulation of miRNAs and target genes is challenging our understanding of the gene-regulatory role of miRNAs in vivo and has important implications for the use of these RNAs in therapeutic settings.
                Bookmark

                Author and article information

                Contributors
                Journal
                PeerJ
                PeerJ
                PeerJ
                PeerJ
                PeerJ Inc. (San Diego, USA )
                2167-8359
                15 April 2022
                2022
                : 10
                : e13233
                Affiliations
                [1 ]Key Laboratory of Xinjiang Endemic and Ethnic Diseases/NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, School of Medicine, Shihezi University , Shihezi, Xinjiang, China
                [2 ]Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland (UQ) , St Lucia, Brisbane, Australia
                [3 ]School of Medicine, Hangzhou Normal University , Hangzhou, Zhejiang, China
                [4 ]Department of Cellular and Molecular Biology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute , Beijing, Beijing, China
                Article
                13233
                10.7717/peerj.13233
                9014853
                35444864
                7a6053ff-17e0-4456-b095-09e047365e7b
                © 2022 Wu et al.

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

                History
                : 8 November 2021
                : 17 March 2022
                Funding
                Funded by: National Natural Science Foundation of China
                Award ID: NSFC81760362
                Funded by: International Cooperation Program of Shihezi University
                Award ID: GJHZ202102
                Funded by: Xinjiang Autonomous Region Postgraduate Research and Innovation Project
                Award ID: XJ2020G124, XJ2021G122
                Funded by: National College Students Innovation and Entrepreneurship Training Program
                Award ID: 202110759020
                This study was supported by the Fund of National Natural Science Foundation of China (NSFC81760362), the International Cooperation Program of Shihezi University (GJHZ202102), the Xinjiang Autonomous Region Postgraduate Research and Innovation Project (XJ2020G124, XJ2021G122) and the National College Students Innovation and Entrepreneurship Training Program (202110759020). The funders had a role in study design, data collection and analysis. The funders had no role in the decision to publish or the preparation of the manuscript.
                Categories
                Biochemistry
                Cell Biology
                Molecular Biology

                mir-34a-5p,kaposi’s sarcoma–associated herpesvirus,c-fos,proliferation,migration

                Comments

                Comment on this article